YSI 2900 Biochemical Analyzer

Overview

The YSI 2900 Biochemical Analyzer is a high-precision, continuous-flow enzymatic biosensor system engineered for rapid, selective quantification of key metabolites in complex biological matrices. Unlike spectrophotometric or chromatographic platforms, the YSI 2900 employs immobilized enzyme electrodes operating on amperometric detection principles: analyte-specific enzymes (e.g., glucose oxidase, lactate oxidase) catalyze substrate conversion at the electrode surface, generating a proportional electrochemical current linearly related to concentration. This architecture delivers real-time, single-analyte resolution without cross-reactivity—even in turbid, viscous, or cell-dense samples such as microbial fermentation broths or whole blood—eliminating the need for centrifugation, filtration, or derivatization. Its measurement cycle completes within 60 seconds per analyte, with coefficient of variation (CV) consistently below 2% and linearity maintained within ±5% across clinically and industrially relevant dynamic ranges. Designed for integration into GLP-compliant laboratories and cGMP bioprocess environments, the instrument meets CE and RoHS directives and supports traceable operation through configurable audit trails and electronic signatures.

Key Features

• Continuous-flow amperometric biosensing with immobilized enzyme electrodes for direct, interference-resistant detection
• Modular sensor architecture: base platform supports up to six independent analyte channels (expandable via YSI 2950 configuration)
• Patented cavity-flow hydrodynamic design prevents clogging in samples containing >1 × 10⁸ cells/mL—no pre-filtration required
• Touchscreen graphical user interface with multilingual support (English, German, French, Spanish, Portuguese, Italian, Korean, Chinese)
• Onboard data management: internal storage, SD card export (CSV/Excel), USB/Ethernet/RS232/OPC UA connectivity
• Configurable sample volume (10–50 µL) and automated calibration routines using buffer, calibrant, and linearity standards
• Compliance-ready software with embedded training modules, electronic logbooks, and FDA 21 CFR Part 11–compatible audit trail options

Sample Compatibility & Compliance

The YSI 2900 accepts undiluted, unprocessed liquid samples including mammalian and microbial cell culture supernatants, fermentation broth, whole blood, serum, plasma, and food-grade extracts. Its robust fluidics tolerate particulates, proteins, and lipids that would foul conventional HPLC or photometric systems. Regulatory alignment includes CE marking per Directive 2017/746 (IVDR) for in vitro diagnostic use where applicable, RoHS 2011/65/EU conformance, and compatibility with ISO 17025–accredited quality systems. For biopharmaceutical process monitoring, the analyzer supports PAT (Process Analytical Technology) frameworks under ICH Q5 and Q8 guidelines; when paired with the optional YSI Sitini online sampling module, it enables sterile, in-line integration with bioreactors—including SIP (steam-in-place) compatibility up to 135 °C.

Software & Data Management

YSI’s proprietary BioView™ software provides a validated, secure environment for method setup, calibration, and result review. All user actions—including parameter changes, calibration events, and result approvals—are time-stamped and logged with operator ID. Data exports include full metadata (sample ID, timestamp, sensor ID, calibration status, raw current values) and comply with LIMS interoperability standards. The system supports role-based access control, electronic signatures per 21 CFR Part 11 Annex 11, and configurable retention policies. Raw signal traces and calibration curves are archived alongside final concentrations, enabling retrospective reprocessing and uncertainty analysis. Optional database integration permits direct SQL insertion or ODBC linkage for enterprise-level analytics.

Applications

• Bioprocess Development & Manufacturing: Real-time glucose/lactate monitoring during fed-batch and perfusion cultures; glutamine/glutamate profiling in CHO and HEK cell lines; ammonium tracking for pH control optimization
• Vaccine & Therapeutic Production: Metabolite trending in viral vector manufacturing, mRNA production, and monoclonal antibody processes per USP & EP monographs
• Clinical Research: Whole-blood glucose and lactate quantification in metabolic studies, sepsis diagnostics, and exercise physiology—aligned with CLSI EP9-A3 verification protocols
• Food & Beverage Quality Control: Ethanol and lactate assays in fermented products (e.g., tomato paste, yogurt, wine); sucrose/galactose monitoring in dairy processing
• Academic & Industrial Biotechnology: High-throughput screening of microbial strains for biofuel (ethanol, butanol), organic acid (lactic, succinic), or specialty chemical production

FAQ

What regulatory standards does the YSI 2900 meet for use in GMP environments?
The instrument complies with CE IVDR (2017/746) for IVD applications where validated, supports 21 CFR Part 11 audit trails, and integrates with PAT frameworks per FDA guidance.
Can the YSI 2900 analyze whole blood without preprocessing?
Yes—the cavity-flow design and enzyme electrode specificity allow direct analysis of anticoagulated whole blood for glucose and lactate without centrifugation or dilution.
How is calibration verified and maintained over time?
Calibration uses three-point linearity verification (low/mid/high standards); software logs drift metrics and triggers alerts if slope deviation exceeds ±5% or intercept shifts beyond defined thresholds.
Is the YSI Sitini online sampling system sterile-compatible?
Yes—Sitini components are autoclavable (135 °C, 30 min) and support SIP integration with stainless-steel bioreactor manifolds via sanitary tri-clamp fittings.
What data security measures are implemented in BioView™ software?
Role-based authentication, encrypted local storage, hashed password policies, session timeout enforcement, and immutable audit logs meeting ISO 27001-aligned controls.